MAPT and Alzheimer disease: In an AD mouse model, insulin treatment showed the mitigation of both long-term and short-term memory as well as learning impairments when compared to the controls, and this was associated with a reduced Aβ plaque load and hyper-phosphorylated tau [69,70].